Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition by Eytan Breman, Jurjen M. Ruben, Kees L. Franken, Mirjam H. M. Heemskerk, Dave L. Roelen, Frans H. Claas, Cees van Kooten

Get full text

Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. by Yi Zhang, Yeuying Liu, Kelly M Moxley, Lucy Golden-Mason, Lucy Golden-Mason, Michael G Hughes, Tongxin Liu, Mirjam H M Heemskerk, Hugo R Rosen, Michael I Nishimura

Get full text

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion by Miranda H Meeuwsen, Laura T Morton, Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, Marleen M van Loenen, J H Frederik Falkenburg, Mirjam H M Heemskerk

Get full text

Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody by Willemijn van der Wulp, Dennis F. G. Remst, Carli S. Koster, Anne K. Wouters, Maaike E. Ressing, Janine Schuurman, Sander I. van Kasteren, Boris Bleijlevens, Rob C. Hoeben, Lars Guelen, Mirjam H. M. Heemskerk

Get full text

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets by Marije A.J. de Rooij, Miranda H. Meeuwsen, Anne K. Wouters, Dennis F.G. Remst, Renate S. Hagedoorn, Dirk M. van der Steen, Els M.E. Verdegaal, Tassilo L.A. Wachsmann, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation by Sine R Hadrup, Marieke Griffioen, J H Frederik Falkenburg, Mirjam H M Heemskerk, Marian van de Meent, Michel G D Kester, Kyra J Fuchs, Marcus Göransson, Natasja W Ettienne, Rob C M de Jong, Eva A S Koster, Constantijn J M Halkes, Ferenc Scheeren, Peter van Balen

Get full text

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines by Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Romy C. Dijkland, Marian van de Meent, Kayleigh van Dijk, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, J.H. Frederik Falkenburg, Ruben A.L. de Groen, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Birgit I. Lissenberg-Witte, Arnon P. Kater, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Debbie van Baarle, Rory D. de Vries, Tom van Meerten, Pim G.N.J. Mutsaers, Abraham Goorhuis, Inger S. Nijhof, Mette D. Hazenberg, Mirjam H.M. Heemskerk, Caroline E. Rutten, COBRA KAI study team

Get full text